Abstract
Sclerosing mesenteritis (SM) is a rare, idiopathic disorder that involves the adipose tissue of the mesentery of the small intestine and sometimes colon. It is characterized by chronic, nonspecific fibrous inflammation in the mesenteric fat with varying degrees of fat necrosis, chronic inflammation, and fibrosis. The pathogenic mechanisms may involve a nonspecific response to various stimuli, including malignancy, abdominal trauma, and surgery. SM has also been associated with other chronic fibroinflammatory disorders and may arise in the context of IgG4-related disease. The disease typically affects middle-aged to older adults and is more common in men. After careful age-appropriate cancer screening, a diagnosis of SM can be made with near-certainty with abdominal CT scanning, thereby obviating the need for routine biopsy. Many patients are only mildly symptomatic and SM may even be an incidental finding in otherwise asymptomatic patients. However, the disease may also have a chronic, debilitating course. Treatment should be guided by the severity of signs and symptoms and may include different drugs, surgical procedures or both. Herein, we provide an overview of this intriguing disease, including its potential pathogenesis, pathological findings, the possible association with other fibroinflammatory disorders, and outline the diagnostic and therapeutic approach to this disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
PubMed search strategy:
(“panniculitis, peritoneal”[MeSH Terms] OR (“panniculitis”[All Fields] AND “peritoneal”[All Fields]) OR “peritoneal panniculitis”[All Fields] OR (“mesenteric”[All Fields] AND “panniculitis”[All Fields]) OR “mesenteric panniculitis”[All Fields]) OR (“panniculitis, peritoneal”[MeSH Terms] OR (“panniculitis”[All Fields] AND “peritoneal”[All Fields]) OR “peritoneal panniculitis”[All Fields] OR (“sclerosing”[All Fields] AND “mesenteritis”[All Fields]) OR “sclerosing mesenteritis”[All Fields]) OR (“panniculitis, peritoneal”[MeSH Terms] OR (“panniculitis”[All Fields] AND “peritoneal”[All Fields]) OR “peritoneal panniculitis”[All Fields] OR (“mesenteric”[All Fields] AND “lipodystrophy”[All Fields]) OR “mesenteric lipodystrophy”[All Fields])
- 2.
From their study [1], we analyzed data of individual patients receiving medical treatment without surgical intervention with follow-up ≥ one month and categorized patients according to four different treatment regimens. Per treatment category we calculated the number of patients, mean age (y), male sex (n), response rate (n, %) and mean follow-up (range). We also calculated dose range per drug and mean (initial) dose (mg/day) and duration (month) of prednisone and tamoxifen in those patients who received medical treatment including both prednisone and tamoxifen.
References
Akram S, Pardi DS, Schaffner JA, Smyrk TC (2007) Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol 5(5):589–596
Alhazzani W, Al-Shamsi HO, Greenwald E, Radhi J, Tse F (2015) Chronic abdominal pain secondary to mesenteric panniculitis treated successfully with endoscopic ultrasonography-guided celiac plexus block: a case report. World J Gastrointest Endosc 7(5):563–566. doi:10.4253/wjge.v7.i5.56
Bala A, Coderre SP, Johnson DR, Nayak V (2001) Treatment of sclerosing mesenteritis with corticosteroids and azathioprine. Can J Gastroenterol 15(8):533–535
Belghiti H, Cazals-Hatem D, Couvelard A, Guedj N, Bedossa P (2009) Sclerosing mesenteritis: can it be a IgG4 dysimmune disease? Ann Pathol 29(6):468–474
Bush RW, Hammar SP Jr, Rudolph RH (1986) Sclerosing mesenteritis. Response to cyclophosphamide. Arch Intern Med 146(3):503–505
Chen TS, Montgomery EA (2008) Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders? J Clin Pathol 61(10):1093–1097
Coulier B (2011) Mesenteric panniculitis. Part 1: MDCT--pictorial review. JBR–BTR 94(5):229–240
Coulier B (2011) Mesenteric panniculitis. Part 2: prevalence and natural course: MDCT prospective study. JBR–BTR 94(5):241–246
Crane JT, Aguilar MJ, Grimes OF (1955) Isolated lipodystrophy, a form of mesenteric tumor. Am J Surg 90(2):169–179
Daskalogiannaki M, Voloudaki A, Prassopoulos P, Magkanas E, Stefanaki K, Apostolaki E et al (2000) CT evaluation of mesenteric panniculitis: prevalence and associated diseases. Am J Roentgenol 174(2):427–431
Daumas A, Agostini S, Villeret J, Ah-Soune P, Emungania O, Granel B (2012) Spontaneous resolution of severe, symptomatic mesocolic panniculitis: a case report. BMC Gastroenterol 12:59
Delgado Plasencia L, Rodríguez Ballester L, López-Tomassetti Fernández EM, Hernández Morales A, Carrillo Pallarés A, Hernández Siverio N (2007) Mesenteric panniculitis: experience in our center. Rev Esp Enferm Dig 99(5):291–297
Durst AL, Freund H, Rosenmann E, Birnbaum D (1977) Mesenteric panniculitis: review of the literature and presentation of cases. Surgery 81(2):203–211
Ehrenpreis ED, Boiskin I, Schaefer K (2008) Chylous ascites in a patient with mesenteric panniculits. J Clin Gastroenterol 42(3):327–328
Emory TS, Monihan JM, Carr NJ, Sobin LH (1997) Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: a single entity? Am J Surg Pathol 21(4):392–398
Fasoulas K, Beltsis A, Katsinelos T, Dimou E, Arvaniti M, Charsoula A et al (2012) Efficacy of colchicine in the treatment of mesenteric panniculitis in a young patient. Saudi J Gastroenterol 18(2):146–148
Genereau T, Bellin MF, Wechsler B, Le TH, Bellanger J, Grellet J et al (1996) Demonstration of efficacy of combining corticosteroids and colchicine in two patients with idiopathic sclerosing mesenteritis. Dig Dis Sci 41(4):684–688
Ginsburg PM, Ehrenpreis ED (2002) A pilot study of thalidomide for patients with symptomatic mesenteric panniculitis. Aliment Pharmacol Ther 16(12):2115–2122
Gögebakan O, Albrecht T, Osterhoff MA, Reimann A (2013) Is mesenteric panniculitis truely a paraneoplastic phenomenon? A matched pair analysis. Eur J Radiol 82(11):1853–1859
Goldoni M, Bonini S, Urban ML, Palmisano A, De Palma G, Galletti E et al (2014) Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study. Ann Intern Med 161(3):181–188
Gottschalk U, Nitzsche C, Felber J, Dietrich CF (2012) Enteroscopy and imaging in sclerosing mesenteritis. Z Gastroenterol 50(9):1013–1017
Hasbahçecı M, Başak F, Seker M, Canbak T, Kiliç A, Alımoğlu O (2012) Spontaneous remission of sclerosing mesenteritis. Turk J Gastroenterol 23(4):378–380
Hemaidan A, Vanegas F, Alvarez OA, Arroyo MA, Lee M (1999) Mesenteric lipodystrophy with fever of unknown origin and mesenteric calcifications. South Med J 92(5):513–516
Horton KM, Lawler LP, Fishman EK (2003) CT findings in sclerosing mesenteritis (panniculitis): spectrum of disease. Radiographics 23(6):1561–1567
Iwanicki-Caron I, Savoye G, Legros JR, Savoye-Collet C, Herve S, Lerebours E (2006) Successful management of symptoms of steroid-dependent mesenteric panniculitis with colchicine. Dig Dis Sci 51(7):1245–1249
Jura V (1924) Sulla mesenterite retrattile e sclerosante. Policlinico (Sez Chir) 31:575
Kakitsubata Y, Umemura Y, Kakitsubata S, Tamura S, Watanabe K, Abe Y et al (1993) CT and MRI manifestations of intraabdominal panniculitis. Clin Imaging 17(3):186–188
Katsanos KH, Ioachim E, Michail M, Price AC, Agnantis N, Kappas A et al (2004) A fatal case of sclerosing mesenteritis. Dig Liver Dis 36(2):153–156
Katz ME, Heiken JP, Glazer HS, Lee JK (1985) Intraabdominal panniculitis: clinical, radiographic, and CT features. Am J Roentgenol 145(2):293–296
Kelly JK, Hwang WS (1989) Idiopathic retractile (sclerosing) mesenteritis and its differential diagnosis. Am J Surg Pathol 13(6):513–521
Kida T, Suzuki K, Matsuyama T, Okita M, Isozaki Y, Matsumoto N et al (2011) Sclerosing mesenteritis presenting as protein-losing enteropathy: a fatal case. Intern Med 50(22):2845–2849
Kipfer RE, Moertel CG, Dahlin DC (1974) Mesenteric lipodystrophy. Ann Intern Med 80(5):582–588
Leung YY, Yao Hui LL, Kraus VB (2015) Colchicine-Update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum. pii: S0049-0172(15)00179-1
Mata JM, Inaraja L, Martin J, Olazabal A, Castilla MT (1987) CT features of mesenteric panniculitis. J Comput Assist Tomogr 11(6):1021–1023
Mazure R, Fernandez MP, Niveloni S, Pedreira S, Vazquez H, Smecuol E et al (1998) Successful treatment of retractile mesenteritis with oral progesterone. Gastroenterology 114(6):1313–1317
McCormack O, Meaney JF, Reynolds JV (2013) Resolving sclerosing mesenteritis. Surgery 153(6):879–880
McLauglin PD, Filippone A, Maher MM (2013) The “misty mesentery”: mesenteric panniculitid and its mimics. AJR Am J Roentgenol 200(2):W116–W123
Minato H, Shimizu J, Arano Y, Saito K, Masunaga T, Sakashita T, Nojima T (2012) IgG4-related sclerosing mesenteritis: a rare mesenteric disease of unknown etiology. Pathol Int 62(4):281–286
Nicholson JA, Smith D, Diab M, Scott MH (2010) Mesenteric panniculitis in Merseyside: a case series and a review of the literature. Ann R Coll Surg Engl 92(6):W31–W34
Nomura Y, Naito Y, Eriguchi N, Kume T, Itai N, Sonoda H et al (2011) A case of IgG4-related sclerosing mesenteritis. Pathol Res Pract 207(8):518–521
Ogden WW, Bradburn DM, Rives JD (1960) Panniculitis of the mesentery. Ann Surg 151:659–668
Ogden WW, Bradburn DM, Rives JD (1965) Mesenteric pannicultitis: review of 27 cases. Ann Surg 161:864–875
Okazaki K, Uchida K, Miyoshi H, Ikeura T, Takaoka M, Nishio A (2011) Recent concepts of autoimmune pancreatitis and IgG4-related disease. Clin Rev Allergy Immunol 41(2):126–138
Parra-Davila E, McKenney MG, Sleeman D, Hartmann R, Rao RK, McKenney K et al (1998) Mesenteric panniculitis: case report and literature review. Am Surg 64(8):768–771
Roginsky G, Alexoff A, Ehrenpreis ED (2015) Initial findings of an open-label trial of low-dose naltrexone for symptomatic mesenteric panniculitis. J Clin Gastroenterol 49(9):794–795. doi:10.1097/MCG.0000000000000398
Rosón N, Garriga V, Cuadrado M, Pruna X, Carbó S, Vizcaya S, Peralta A, Martinez M, Zarcero M, Medrano S (2006) Sonographic findings of mesenteric panniculitis: correlation with CT and literature review. J Clin Ultrasound 34(4):169–176
Rothlein LR, Shaheen AW, Vavalle JP, Smith SV, Renner JB, Shaheen NJ, Tarrant TK (2010) Sclerosing mesenteritis successfully treated with a TNF antagonist. BMJ Case Rep 2010:bcr0720103145. doi:10.1136/bcr.07.2010.3145
Sabate JM, Torrubia S, Maideu J, Franquet T, Monill JM, Perez C (1999) Sclerosing mesenteritis: imaging findings in 17 patients. Am J Roentgenol 172(3):625–629
Salvarani C, Valli R, Boiardi L, Pipitone N, Nicoli F, Muratore F (2011) IgG4-associated sclerosing mesenteritis. Clin Exp Rheumatol 29(1 Suppl 64):S79–S80
Schaffler A, Scholmerich J, Buchler C (2005) Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2(2):103–111
Scudiere JR, Shi C, Hruban RH, Herman JM, Fishman EK, Schulick RD et al (2010) Sclerosing mesenteritis involving the pancreas: a mimicker of pancreatic cancer. Am J Surg Pathol 34(4):447–453
Seo BK, Ha HK, Kim AY, Kim TK, Kim MJ, Byun JH et al (2003) Segmental misty mesentery: analysis of CT features and primary causes. Radiology 226(1):86–94
Smith ZL, Sifuentes H, Deepak P, Ecanow DB, Ehrenpreis ED (2013) Relationship between mesenteric abnormalities on computed tomography and malignancy: clinical findings and outcomes of 359 patients. J Clin Gastroenterol 47(5):409–414
Stone JH (2012) IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 29(4):177–190
Tytgat GN, Roozendaal K, Winter W, Esseveld MR (1980) Successful treatment of a patient with retractile mesenteritis with prednisone and azathioprine. Gastroenterology 79(2):352–356
Valls C (2000) Fat-ring sign in sclerosing mesenteritis. Am J Roentgenol 174(1):259–260
Van Bommel EF, Pelkmans LG, Van DH, Hendriksz TR (2013) Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Intern Med 24(5):444–450
Van Breda-Vriesman AC, Schuttevaer HM, Coerkamp EG, Puylaert JB (2004) Mesenteric panniculitis: US and CT features. Eur Radiol 14(12):2242–2248
Van Putte-Katier N, van Bommel EF, Elgersma OE, Hendriksz TR (2014) Mesenteric panniculitis: prevalence, clinicoradiological presentation and 5-year follow-up. Br J Radiol 87(1044):20140451
Venkataramani A, Behling CA, Lyche KD (1997) Sclerosing mesenteritis: an unusual cause of abdominal pain in an HIV-positive patient. Am J Gastroenterol 92(6):1059–1060
Wat S, Harish S, Winterbottom A, Choudhary AK, Freeman AH (2006) The CT appearances of sclerosing mesenteries and associated diseases. Clin Radiol 61:652–658
Weaver J, Goldblum JR, Turner S, Tubbs RR, Wang WL, Lazar AJ, Rubin BP (2009) Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma. Mod Pathol 22(1):66–70
Wilkes A, Griffin N, Dixon L, Dobbs B, Frizelle FA (2012) Mesenteric panniculitis: a paraneoplastic phenomenon? Dis Colon Rectum 55(7):806–809
Zen Y, Fujii T, Harada K et al (2007) Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45:1538–1546
Zhao LN, Han WY, Lu L, Yu T, Li JY, Min XH et al (2014) Clinical features and expressions of Foxp3 and IL-17 in type 1 autoimmune pancreatitis in China. Med Sci Monit 20:2720–2728
Zissin R, Metser U, Hain D, Even-Sapir E (2006) Mesenteric panniculitis in oncologic patients: PET-CT findings. Br J Radiol 79(397):37–43
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
van Bommel, E.F.H., van Putte-Katier, N. (2017). Sclerosing Mesenteritis. In: Vaglio, A. (eds) Systemic Fibroinflammatory Disorders. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-319-41349-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-41349-5_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41347-1
Online ISBN: 978-3-319-41349-5
eBook Packages: MedicineMedicine (R0)